🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: ESSPRI

Found 15 matching trials

Eye Dryness Evaluation in Primary Sjögren's Syndrome

N/A

The objective of this observational study is to develop new tools to assess...

Status

Completed

Location

CHU de BREST

Start Date

2019-11-20

Trial ID

NCT03614299

Treatments Being Tested

Ecological symptom measurements using a webapp Interferometry

A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

PHASE3

Primary Objective: To evaluate the effect of dazodalibep on systemic manif...

Status

Active Not Recruiting

Location

Arizona Arthritis & Rheumatology Associates - Avondale

Start Date

2024-01-24

Trial ID

NCT06104124

Treatments Being Tested

Dazodalibep Placebo

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

PHASE3

The purpose of this study is to demonstrate the efficacy and safety of iana...

Status

Recruiting

Location

Sun Valley Arthritis Center Ltd

Start Date

2026-07-16

Trial ID

NCT07621809

Treatments Being Tested

VAY736 Placebo

Exosome-miRNA and Transcriptome Profiling of Dry Eye Syndrome and Sjogren's Syndrome

N/A

This study combines data from two trials testing acupuncture (ACUDES) and a...

Status

Not Yet Recruiting

Location

Ching-Mao Chang

Start Date

2024-07-01

Trial ID

NCT06475027

Treatments Being Tested

TBDESJS Acupuncture

Objective Measurement With TCM Pattern for AIDDES

N/A

To explore the association with TCM pattern and TCM tongue diagnosis for Au...

Status

Unknown

Location

Ching-Mao Chang

Start Date

2021-02-01

Trial ID

NCT04747288

Treatments Being Tested

Traditional Chinese Medicine pattern Traditional Chinese Medicine tongue diagnosis Heart rate variability Schirmer's test Ocular Surface Diseast Index (OSDI)EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI)36-Item Short Form Survey (SF-36)

Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome

N/A

By analyzing the differential proteins in exosomes, this study aims to unde...

Status

Recruiting

Location

Ching-Mao

Start Date

2025-01-16

Trial ID

NCT06771427

Treatments Being Tested

acupuncture GB20 or GB20 plus BL2 Chinese herbal tea TBDESJS

Fatigue in Primary Sjögren's Syndrome

N/A

Fatigue is a common clinical finding in Primary Sjögren's syndrome (PSS). I...

Status

Completed

Location

Koray Ayar

Start Date

2021-01-04

Trial ID

NCT04802577

Treatments Being Tested

FACT-F questionnaire Beck Depression Inventory Beck Anxiety Inventory Insomnia severity index.ESSPRI ESSDAI Pain Detect Questionnaire

Sjögren and Gynecologic Considerations

N/A

Sjögren's syndrome is an autoimmune disorder characterized by glandular and...

Status

Completed

Location

Ankara City Hospital

Start Date

2021-03-01

Trial ID

NCT05670535

Treatments Being Tested

Visual analogue scale (VAS) for dyspareunia Visual analogue scale (VAS) for vaginal dryness The European League Against Rheumatism Sjögren's Syndrome Disease Activity Index (ESSDAI)The European League Against Rheumatism Sjögren's Syndrome Patient Reported Index (ESSPRI)

A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

PHASE2

To evaluate efficacy, safety, and tolerability of DDY391 up to 52 weeks in ...

Status

Not Yet Recruiting

Location

Multiple Locations

Start Date

2026-08-27

Trial ID

NCT07737743

Treatments Being Tested

DDY391 Placebo

Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome

PHASE2

This study was to evaluate the safety, efficacy, pharmacokinetics (PK) and ...

Status

Completed

Location

North GA Rheumatology Group PC

Start Date

2019-10-01

Trial ID

NCT03905525

Treatments Being Tested

CFZ533 Placebo

Previous Next